We are live on ! Find out more
NYLT

New York Life Trust Portfolio holdings

AUM $2.05M
1-Year Est. Return 23.85%
This Fund
S&P 500
This Quarter Est. Return
+12.57%
1 Year Est. Return
+23.85%
3 Year Est. Return
+57.22%
5 Year Est. Return
10 Year Est. Return
AUM
$22M
AUM Growth
+$2.05M
Cap. Flow
-$229K
Cap. Flow %
-1.04%
Top 10 Hldgs %
20.43%
Holding
232
New
40
Increased
52
Reduced
95
Closed
43

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$179K
2
MRK icon
Merck
MRK
+$163K
3
HAL icon
Halliburton
HAL
+$138K
4
VIAB
Viacom Inc. Class B
VIAB
+$131K
5
MO icon
Altria Group
MO
+$124K

Sector Composition

Rank Sector Weight
1 Technology 15.8%
2 Financials 14.52%
3 Healthcare 14.1%
4 Industrials 11.71%
5 Consumer Staples 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMC
226
DELISTED
EMC CORPORATION
EMC
-3,489
Closed -$89K
FNFG
227
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
-1,963
Closed -$20K
GMCR
228
DELISTED
KEURIG GREEN MTN INC
GMCR
-161
Closed -$12K
XL
229
DELISTED
XL Group Ltd.
XL
-485
Closed -$15K
SIVB
230
DELISTED
SVB Financial Group
SIVB
-632
Closed -$55K
TSS
231
DELISTED
Total System Services, Inc.
TSS
-2,366
Closed -$70K
SPN
232
DELISTED
Superior Energy Services, Inc.
SPN
-4
Closed -$1K

Similar funds

New York Life Trust's Q4 2013 Portfolio in Review

As of Q4 2013, New York Life Trust held 232 positions worth $22M, up 10% from $19.9M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

New York Life Trust's Q4 2013 filing shows 40 new, 52 increased, 95 reduced and 43 closed positions. Its largest new stake was Halliburton: 2,668 shares worth $135K. The largest sale was Bristol-Myers Squibb, an estimated $198K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • New York Life Trust's largest Q4 2013 buy was Halliburton: 2,668 shares worth $135K.
  • New York Life Trust added most to UnitedHealth in Q4 2013, an estimated $179K increase.
  • New York Life Trust's biggest Q4 2013 reduction was Bristol-Myers Squibb, cutting an estimated $198K.
  • New York Life Trust fully exited Cencora in Q4 2013, selling an estimated $111K.
  • New York Life Trust's ten largest holdings make up 20% of its $22M portfolio in Q4 2013.
  • New York Life Trust opened 40 new positions and closed 43 in Q4 2013.
  • New York Life Trust's portfolio value rose 10% quarter-over-quarter to $22M.

Based on New York Life Trust's 13F filing for Q4 2013, filed 14 Feb 2014.